Phenyl-(4-Phenyl-Pyrimidin-2-YL)-amines for enhancing immunotolerance

Simple item page
dc.contributor.assigneeNovartis institute for Biomedical Research, Inc. Cambridge
dc.contributor.authorWoisetschlager, M.
dc.contributor.authorHauben, E.
dc.contributor.authorRoncarolo, M.
dc.date.issued2008
dc.descriptionM. Woisetschlager, E. Hauben, M. G. Roncarolo (assignee Novartis institute for Biomedical Research, Inc.). US 2008/0279829 A1 (PCT/EP2006/009406) filed Sep. 27, 2006; published Nov. 13, 2008.
dc.description.abstractThe use of a phenyl-(4-phenyl-pyrimidin-2-yl)-amine for the preparation of a medicament for enhancing immunotolerance in a mammal; and uses, methods, processes and pharmaceutical combinations and compositions comprising such phenyl-(4-phenyl-pyrimidin-2-yl)-amine.
dc.description.statementofresponsibilityInvented by Maximilian Woisetschlaeger, Ehud Hauben, Maria Grazia Roncarolo; assigned to Novartis institute for Biomedical Research, Inc.
dc.description.urihttp://www.patentlens.net/patentlens/patent/US_2008_0279829_A1/en/
dc.identifier.orcidHauben, E. [0000-0002-6062-411X]
dc.identifier.patentUS 2008/0279829 A1
dc.identifier.urihttp://hdl.handle.net/2440/74626
dc.language.isoen
dc.titlePhenyl-(4-Phenyl-Pyrimidin-2-YL)-amines for enhancing immunotolerance
dc.typePatent
pubs.publication-statusPublished

Files

Collections

Surgery publications